EVOKE-02: A phase 2 study of sacituzumab govitecan (SG) plus pembrolizumab (pembro) with or without platinum chemotherapy in first-line metastatic non–small cell lung cancer (NSCLC... von Garon, Edward B., Liu, Stephen V., Owen, Scott Peter, Reck, Martin, Neal, Joel W., Vicente, David, Mekan, Sabeen Fatima, Safavi, Farnoush, Fernando, Nelumka, Mok, Tony S. K.

Volltext

PPD01.06 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non–Small Cell Lung Cancer: Preliminary Results of the EVOKE-2 Study von Patel, Jyoti, Cho, Byoung Chul, Dols, Manuel Cobo, Cabanillas, Roxanna Reyes, Baz, David Vicente, Pradera, Jose Fuentes, Grisanti, Salvatore, Gabayan, Afshin E., Lee, Ki Hyeong, Cho, Eun Kyung, Mekan, Sabeen Fatima, Safavi, Farnoush, Fernando, Nalumka, Chisamore, Michael J., Reck, Martin

Volltext

Personalized Dosimetry using 131I-anti-CD45-Apamistamab (Iomab-B) Prior to High-dose Myeloablative Radioimmunotherapy for Hematopoietic Stem Cell Transplant (HCT) in Active, Relaps... von Griffeth, Landis, Passalaqua, Susan, Wiseman, Gregory, Avril, Norbert, Yap, Wendell, Chen, Ming-Kai, Wagner, Robert, Natwa, Mona, Chasen, Beth, Lamonica, Dominick, Konerth, Sandy, Fisher, Darrell, Safavi, Farnoush, Berger, Mark, Reddy, Vijay, Pandit-Taskar, Neeta

Volltext

Optimizing Dosimetry Imaging in High-dose Radioimmunotherapy Using the Novel, Anti-CD45 Re-induction and Targeted Conditioning Agent Iodine (131I) Apamistamab [Iomab-B] in Patients... von Pandit-Taskar, Neeta, Passalaqua, Susan, Wiseman, Gregory, Avril, Norbert, Yap, Wendell, Chen, Ming-Kai, Wagner, Robert, Natwa, Mona, Chasen, Beth, Lamonica, Dominick, Konerth, Sandy, Fisher, Darrell, Safavi, Farnoush, Berger, Mark, Reddy, Vijay, Griffeth, Landis

Volltext